Correction to: npj Vaccines (2018) https://doi.org/10.1038/s41541-018-0050-z, Published online 28 March 2018
A source of funding was mistakenly left out of the Acknowledgements. This research was also funded by NIAID/HRSA Interagency Agreement no. AAI15006-004-00000.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41541-018-0050-z.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Duthie, M.S., Pena, M.T., Ebenezer, G.J. et al. Author Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection. npj Vaccines 3, 18 (2018). https://doi.org/10.1038/s41541-018-0055-7
Published:
DOI: https://doi.org/10.1038/s41541-018-0055-7
